Galicia has approved a €15.6 million investment to supply gene therapy for hemophilia B, becoming the first region in Spain to do so. The therapy, Etranacogene...
Spark is getting positive results with SPK-9001, an alternative drug for the treatment of a hereditary blood disorder.